Insight Molecular Diagnostics (IMDX) Liabilities and Shareholders Equity (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Liabilities and Shareholders Equity of $29.44 million for Q2 2026, down 41.7% from $50.52 million a year earlier and down 27.2% from the prior quarter.
Powered by 
Analysis
Insight Molecular Diagnostics (IMDX) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends
At the end of FY2025, Insight Molecular Diagnostics' Liabilities and Shareholders Equity came in at $25.76 million, down 26.6% from FY2024.
- Annual Liabilities and Shareholders Equity has declined for four consecutive years, with a five-year compound annual growth rate of -14.2% (FY2020 to FY2025).
- In prior years, Insight Molecular Diagnostics' Liabilities and Shareholders Equity was $35.08 million in FY2024 (-53.2%), $74.89 million in FY2023 (-25.2%), $100.09 million in FY2022 (-37.3%) and $159.56 million in FY2021 (+187.9%).
- Quarterly Liabilities and Shareholders Equity has run from a low of $25.76 million in Q4 2025 to a high of $171.05 million in Q2 2022 over five years.
- On a year-over-year basis, Liabilities and Shareholders Equity has declined in each of the last 17 quarters, with an average decline of 31.6% over the last eight quarters.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q3 2021, with growth of 191.4%; the weakest was Q4 2024, with a decline of 53.2%.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $40.43 million (Q1 2026), $25.76 million (Q4 2025) and $43.94 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 113.17 Bn |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 109.22 Bn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 92.37 Bn |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 20.88 Bn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 93.31 Bn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | 47.93 Bn |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 45.22 Bn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 13.87 Bn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 50.73 Bn |
| 10 | Insight Molecular Diagnostics | 117.12 Mn | 40.83 Mn | 157,000.00 | 29.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.44 Mn |
| Mar 31, 2026 | 40.43 Mn |
| Dec 31, 2025 | 25.76 Mn |
| Sep 30, 2025 | 43.94 Mn |
| Jun 30, 2025 | 50.52 Mn |
| Mar 31, 2025 | 60.36 Mn |
| Dec 31, 2024 | 35.08 Mn |
| Sep 30, 2024 | 70.22 Mn |
| Jun 30, 2024 | 74.72 Mn |
| Mar 31, 2024 | 70.97 Mn |
| Dec 31, 2023 | 74.89 Mn |
| Sep 30, 2023 | 81.59 Mn |
| Jun 30, 2023 | 87.54 Mn |
| Mar 31, 2023 | 82.80 Mn |
| Dec 31, 2022 | 100.09 Mn |
| Sep 30, 2022 | 157.34 Mn |
| Jun 30, 2022 | 171.05 Mn |
| Mar 31, 2022 | 146.27 Mn |
| Dec 31, 2021 | 159.56 Mn |
| Sep 30, 2021 | 168.34 Mn |
API Access
Insight Molecular Diagnostics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=IMDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "IMDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=IMDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();